CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,631,464
- in 9 filings, $6.6M under 10b5-1 plans
Net −$6,631,464. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-05 | Reeve Emma Director | Exercise or conversion 10b5-1 | +734 | $46.54 | $34K | 11,400 |
| 2026-01-05 | Reeve Emma Director | Sale 10b5-1 | −734 | $76.00 | $56K | 10,666 |
| 2026-01-05 | Reeve Emma Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −734 | 0 | ||
| 2026-01-02 | Reeve Emma Director | Grant or award 10b5-1 | +4,000 | 10,666 | ||
| 2026-01-02 | Reeve Emma Director | Grant or award · Stock Option (Right to Buy) 10b5-1 | +3,475 | 3,475 | ||
| 2025-12-03 | Reeve Emma Director | Exercise or conversion 10b5-1 | +733 | $46.54 | $34K | 7,399 |
| 2025-12-03 | Reeve Emma Director | Sale 10b5-1 | −733 | $78.62 | $58K | 6,666 |
| 2025-12-03 | Reeve Emma Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −733 | 734 | ||
| 2025-11-21 | Reeve Emma Director | Exercise or conversion 10b5-1 | +10,000 | $51.16 | $512K | 16,666 |
| 2025-11-21 | Reeve Emma Director | Sale 10b5-1 | −10,000 | $79.50 | $795K | 6,666 |
| 2025-11-21 | Reeve Emma Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −10,000 | 0 | ||
| 2025-11-12 | Reeve Emma Director | Exercise or conversion 10b5-1 | +7,333 | $46.54 | $341K | 13,999 |
| 2025-11-12 | Reeve Emma Director | Sale 10b5-1 | −7,333 | $74.50 | $546K | 6,666 |
| 2025-11-12 | Reeve Emma Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −7,333 | 1,467 | ||
| 2025-10-30 | Reeve Emma Director | Sale 10b5-1 | −3,666 | $69.50 | $255K | 6,666 |
| 2025-10-30 | Reeve Emma Director | Exercise or conversion 10b5-1 | +12,000 | $38.10 | $457K | 18,666 |
| 2025-10-30 | Reeve Emma Director | Sale 10b5-1 | −12,000 | $69.50 | $834K | 6,666 |
| 2025-10-30 | Reeve Emma Director | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −12,000 | 0 | ||
| 2025-10-03 | Reeve Emma Director | Exercise or conversion 10b5-1 | +10,000 | $39.42 | $394K | 20,332 |
| 2025-10-03 | Reeve Emma Director | Sale 10b5-1 | −3,028 | $65.09 | $197K | 17,304 |
Page 1 of 4 · 65 trades